Infusion rates of recombinant FVIII-FS with PEGylated liposomes in haemophilia A.
Martinowitz
U
U
Lalezari
S
S
Luboshitz
J
J
Lubetsky
A
A
Spira
J
J
D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D005169:Factor VIII / Q000008:administration & dosage*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008081:Liposomes; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols; D013395:Sucrose / Q000008:administration & dosage*; D055815:Young Adult
D008081:Liposomes; C438308:recombinant FVIII, sugar formulated; D011092:Polyethylene Glycols; D013395:Sucrose; D005169:Factor VIII